在线国产一区二区_成人黄色片在线观看_国产成人免费_日韩精品免费在线视频_亚洲精品美女久久_欧美一级免费在线观看

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

Russia tests Avifavir anti-coronavirus drug

Xinhua | Updated: 2020-06-02 09:46
Share
Share - WeChat
Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. [Photo/Agencies]

MOSCOW - Russia is currently carrying out clinical tests of Avifavir, which may prove to be an efficient treatment for COVID-19, the producer of the drug said in a statement on Monday.

"Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in clinical trials," ChemRar Group said in a statement.

Avifavir is produced by a joint venture of the Russian Direct Investment Fund, Russia's sovereign wealth fund, and ChemRar Group, which includes research and development services and investment companies in the field of innovative pharmaceuticals.

The final stage of Avifavir clinical trials involving 330 patients, approved by the Russian Health Ministry on May 21, is ongoing, the statement said.

Efficacy of the drug is above 80 percent, a criterion for a drug with high antiviral activity, it said.

Following the first four days of treatment, 65 percent of the 40 patients who took Avifavir tested negative for coronavirus, which is twice as many as in the standard therapy group, the statement said.

By day 10, the number of patients whose tests returned negative results reached 90 percent, it added.

Avifavir has received a registration certificate from the Russian Health Ministry, thus becoming the first Favipiravir-based drug in the world approved for the treatment of COVID-19, according to the statement.

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan since 2014.

In early June, the first batches of Avifavir will be sent to Russia's Federal Service for Surveillance in Healthcare for approval for use, the statement said.

Deliveries of the first batches of the drug to Russian hospitals are expected on June 11, it added.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品911 | 手机在线免费看av | 婷婷激情五月 | 黄色国产精品 | 亚洲免费视频观看 | 国产欧美日韩视频 | 欧美狠狠操 | 亚洲欧美视频一区 | 丁香五香天堂网 | 青娱乐av| 午夜影院在线观看 | 伊人av综合 | 亚洲第一天堂网 | 91小视频在线观看 | 日本免费在线观看视频 | 3d动漫精品h区xxxxx区 | 久久精品久久久久 | 人人综合 | 天天综合视频 | 国产精品999 | 日日干夜夜爽 | 嫩草嫩草嫩草嫩草 | 99中文字幕 | 精品久久久久久久久久久久久 | 亚洲一区二区国产精品 | 中文字幕理伦片免费看 | 四虎影院永久免费 | 91片黄在线观看 | 在线观看二区 | 亚洲久久久 | 欧美黑粗大 | 日韩理论片| 欧美伊人久久 | 久久久久网站 | 三级黄色片免费看 | 日韩精品一区二区三区免费视频 | 精品日韩在线观看 | 日本综合久久 | 天天爽天天操 | 欧美视频免费 | 欧美精品一区二区三区四区 |